GLP1R and diabetes mellitus: A comprehensive systematic review and meta-analysis published in 2024 demonstrated that treatment with GLP-1 RAs results in significant reductions in disease severity among patients with psoriasis, irrespective of whether they have diabetes mellitus [134,144].